Colgate-Palmolive Company $CL Shares Sold by Richard Bernstein Advisors LLC

Richard Bernstein Advisors LLC reduced its position in Colgate-Palmolive Company (NYSE:CL) by 54.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,968 shares of the company’s stock after selling 36,843 shares during the quarter. Richard Bernstein Advisors LLC’s holdings in Colgate-Palmolive were worth $2,476,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vermillion & White Wealth Management Group LLC grew its holdings in Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares during the last quarter. Copia Wealth Management acquired a new position in shares of Colgate-Palmolive in the third quarter worth $29,000. Cloud Capital Management LLC bought a new stake in Colgate-Palmolive during the third quarter valued at $30,000. MTM Investment Management LLC acquired a new stake in Colgate-Palmolive in the second quarter worth about $39,000. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Colgate-Palmolive in the 2nd quarter worth approximately $44,000. Institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research report on Tuesday, December 9th. Bank of America raised their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. UBS Group increased their target price on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Citigroup lifted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 20th. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $92.90 on Tuesday. The company has a market capitalization of $74.88 billion, a P/E ratio of 35.46, a price-to-earnings-growth ratio of 4.22 and a beta of 0.28. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The company’s 50 day moving average price is $89.24 and its two-hundred day moving average price is $83.08.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the previous year, the company earned $0.91 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is presently 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 35,000 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the sale, the chief operating officer owned 10,415 shares in the company, valued at approximately $985,363.15. This trade represents a 77.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 in the last quarter. 0.41% of the stock is owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.